Caroline Hasselbalch Riley

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

Thomas Stauffer Larsen, Katrine Fladeland Iversen, Esben Hansen et al. · Leukemia Research · 2013 · 90 citations

Inflammation, Thrombosis, Polycythemia Vera +10

The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy

Morten Orebo Holmström, Evelina Martinenaite, Shamaila Munir Ahmad et al. · Leukemia · 2017 · 87 citations

Medicine, Immunology, Immune Checkpoint Inhibitor +8

RG6234, a GPRC5DxCD3 T-Cell Engaging Bispecific Antibody, Is Highly Active in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Intravenous (IV) and First Subcutaneous (SC) Results from a Phase I Dose-Escalation Study

Carmelo Carlo‐Stella, Rita Mazza, Salomon Manier et al. · Blood · 2022 · 86 citations

Molecular profiling of peripheral blood cells from patients with polycythemia vera and related neoplasms: Identification of deregulated genes of significance for inflammation and immune surveillance

Vibe Skov, Thomas Stauffer Larsen, Mads Thomassen et al. · Leukemia Research · 2012 · 68 citations

Inflammation, Polycythemia Vera, Autoimmune Disease +15

Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis

Vibe Skov, Mads Thomassen, Caroline Hasselbalch Riley et al. · Experimental Hematology · 2012 · 61 citations

Thrombopoiesis, Polycythemia Vera, Functional Genomics +11